Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hepatic Encephalopathy - Overview
Hepatic Encephalopathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Hepatic Encephalopathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hepatic Encephalopathy - Companies Involved in Therapeutics Development
Alfasigma SpA
Axcella Health Inc
Cosmo Pharmaceuticals NV
Gilead Sciences Inc
Grifols SA
Kaleido Biosciences Inc
KanLife Sciences Inc
Mallinckrodt Plc
Rebiotix Inc
Takeda Pharmaceutical Co Ltd
Umecrine Cognition AB
Versantis AG
Hepatic Encephalopathy - Drug Profiles
albumin (human) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AXA-1665 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hepatic Encephalopathy - Dormant Projects
Hepatic Encephalopathy - Discontinued Products
Hepatic Encephalopathy - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Hepatic Encephalopathy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Hepatic Encephalopathy, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Hepatic Encephalopathy - Pipeline by Alfasigma SpA, H2 2020
Hepatic Encephalopathy - Pipeline by Axcella Health Inc, H2 2020
Hepatic Encephalopathy - Pipeline by Cosmo Pharmaceuticals NV, H2 2020
Hepatic Encephalopathy - Pipeline by Gilead Sciences Inc, H2 2020
Hepatic Encephalopathy - Pipeline by Grifols SA, H2 2020
Hepatic Encephalopathy - Pipeline by Kaleido Biosciences Inc, H2 2020
Hepatic Encephalopathy - Pipeline by KannaLife Sciences Inc, H2 2020
Hepatic Encephalopathy - Pipeline by Mallinckrodt Plc, H2 2020
Hepatic Encephalopathy - Pipeline by Rebiotix Inc, H2 2020
Hepatic Encephalopathy - Pipeline by Takeda Pharmaceutical Co Ltd, H2 2020
Hepatic Encephalopathy - Pipeline by Umecrine Cognition AB, H2 2020
Hepatic Encephalopathy - Pipeline by Versantis AG, H2 2020
Hepatic Encephalopathy - Dormant Projects, H2 2020
Hepatic Encephalopathy - Discontinued Products, H2 2020